Evidence map›Paper›PMID 28347068›Full record

ReviewNanomaterials (Basel, Switzerland)2015

Role of Physicochemical Properties in Nanoparticle Toxicity.

Seung Won Shin, In Hyun Song, Soong Ho Um

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Inhalable nanoparticle-based drug delivery system for non-small cell lung cancer therapy: promises and challenges.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Review
  5. Review
  6. Transcriptomic profile of TiOArchives of toxicology · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. New 3D Spiral Microfluidic Platform Tested for FeMolecules (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Emerging nanoplatforms towards microenvironment-responsive glioma therapy.Medical oncology (Northwood, London, England) · 2025
    Review
  18. Review
  19. Review
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Seung Won ShinSchool of Chemical Engineering, Sungkyunkwan University, Suwon, Gyeonggi-do 440-746, Korea. seung3885@skku.edu.
In Hyun SongSchool of Chemical Engineering, Sungkyunkwan University, Suwon, Gyeonggi-do 440-746, Korea. songinhyun@skku.edu.
Soong Ho UmSchool of Chemical Engineering, Sungkyunkwan University, Suwon, Gyeonggi-do 440-746, Korea. sh.um@skku.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the recent rapid growth of technological comprehension in nanoscience, researchers have aimed to adapt this knowledge to various research fields within engineering and applied science. Dramatic advances in nanomaterials marked a new epoch in biomedical engineering with the expectation that they would have huge contributions to healthcare. However, several questions regarding their safety and toxicity have arisen due to numerous novel properties. Here, recent studies of nanomaterial toxicology will be reviewed from several physiochemical perspectives. A variety of physiochemical properties such as size distribution, electrostatics, surface area, general morphology and aggregation may significantly affect physiological interactions between nanomaterials and target biological areas. Accordingly, it is very important to finely tune these properties in order to safely fulfill a bio-user's purpose.

Indexed as

nanomaterialsnanotoxicologyphysiological properties

Identifiers

PMID28347068
PMCPMC5304630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.